Back to Results

Evolution Global Acquisition Corp (EVOX)

Featured in Bullish Trend Stocks

Evolution Global Acquisition Corp is a NASDAQ-listed common stock issuer in the financials sector. The company has not yet developed significant operating activities and is focused on completing a business combination, such as a merger, share exchange, asset acquisition, share purchase, or reorganization, with one or more businesses. Incorporated in 2025, it is based in Farmers Branch, Texas.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Next Earnings Date Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Free Cash Flow / Net Income
NASDAQ-EVOX
Not available
Not available
Not available
Fair
0.0%
November 13, 2026
323.5 M
322.7 M
0.0%
66.3%
6.4%
Valuation • Fair Value

Evolution Global Acquisition Corp (NASDAQ-EVOX) Fair Value by Valuation Model

No usable valuation estimate is currently available for Evolution Global Acquisition Corp (NASDAQ-EVOX); fair value and analyst target coverage statuses are shown explicitly below.

Primary Valuation Read

Fair Value

Not available

Data is currently unavailable.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

No usable valuation estimate is currently available for Evolution Global Acquisition Corp (NASDAQ-EVOX). Fair value and the analyst target remain visible as coverage-status fields and should not be read as valuation signals while unavailable.

Profitability • Growth

Profitability & Growth for Evolution Global Acquisition Corp (NASDAQ-EVOX)

Review the profitability and growth indicators currently supported by the latest data.

Revenue Forecast

0 K

Forward revenue estimate.

EBITDA

0 K

Current operating profitability reference.

How to read profitability and growth

This section helps investors review Evolution Global Acquisition Corp (NASDAQ-EVOX) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Evolution Global Acquisition Corp (NASDAQ-EVOX)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

1

Weak quality score that deserves closer review.

FCF / Net Income

6.4%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Evolution Global Acquisition Corp (NASDAQ-EVOX). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Evolution Global Acquisition Corp (NASDAQ-EVOX)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 13, 2026

Days to Earnings

56

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Evolution Global Acquisition Corp (NASDAQ-EVOX), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Sell

The 15-minute technical read for Evolution Global Acquisition Corp (NASDAQ-EVOX) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Neutral

The 1-hour technical read for Evolution Global Acquisition Corp (NASDAQ-EVOX) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Neutral

The daily technical read for Evolution Global Acquisition Corp (NASDAQ-EVOX) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Evolution Global Acquisition Corp (NASDAQ-EVOX) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Evolution Global Acquisition Corp (NASDAQ-EVOX) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ • Fast Investor Answers

Evolution Global Acquisition Corp (NASDAQ-EVOX) Stock FAQ

Data-supported answers about Evolution Global Acquisition Corp (NASDAQ-EVOX), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
Not available
No reliable estimate from the currently supported inputs
Financial Health
Fair
Current financial-health read

A reliable fair value estimate is not currently available for Evolution Global Acquisition Corp (NASDAQ-EVOX). This generally means the latest dataset does not contain enough valid inputs for the valuation models supported by PriceToWorth. The site does not substitute zero or publish an unsupported estimate; availability may change when updated financial data or applicable model inputs become available.

The current financial health read for Evolution Global Acquisition Corp (NASDAQ-EVOX) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Evolution Global Acquisition Corp (NASDAQ-EVOX) is November 13, 2026.

The latest available data indicates no current dividend yield for Evolution Global Acquisition Corp (NASDAQ-EVOX).

The current market capitalization listed for Evolution Global Acquisition Corp is 323.5 M.

The current enterprise value listed for Evolution Global Acquisition Corp is 322.7 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Evolution Global Acquisition Corp is NASDAQ-EVOX, and the stock is listed on NASDAQ.

Evolution Global Acquisition Corp (NASDAQ-EVOX) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Evolution Global Acquisition Corp is 0.0%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Evolution Global Acquisition Corp is 66.3%. Free float helps investors understand how much of the share base is available for public trading.

Similar Capital Markets Stocks View more on NASDAQ

Comparable companies from the same industry, limited to one security per issuer.

MS NYSE Morgan Stanley Fair Value Fair Market Cap 318.2 B
MS_PA NYSE Morgan Stanley Pa ADR Fair Value Undervalued Market Cap 318.2 B
MS_PE NYSE Morgan Stanley Pe ADR Fair Value Undervalued Market Cap 318.2 B
MS_PF NYSE Morgan Stanley Pf ADR Fair Value Undervalued Market Cap 318.2 B
MS_PI NYSE Morgan Stanley Pi ADR Fair Value Undervalued Market Cap 318.2 B
GS NYSE Goldman Sachs Group Inc Fair Value Fair Market Cap 285.2 B
SCHW NYSE Charles Schwab Corp Fair Value Undervalued Market Cap 182 B
BLK NYSE BlackRock Inc Fair Value Fair Market Cap 173.7 B
BX NYSE Blackstone Inc Fair Value Undervalued Market Cap 155.6 B
UBS NYSE UBS Group AG Fair Value Fair Market Cap 154.8 B
IBKR NASDAQ Interactive Brokers Group Inc Fair Value Fair Market Cap 151.4 B
SPGI NYSE S&P Global Inc Fair Value Fair Market Cap 119.5 B
HOOD NASDAQ Robinhood Markets Inc Fair Value Overvalued Market Cap 107.7 B
BNY NYSE Bank of New York Mellon Corp Fair Value Fair Market Cap 104.3 B
CME NASDAQ CME Group Inc Fair Value Fair Market Cap 99.24 B
KKR NYSE KKR & Co LP Fair Value Fair Market Cap 88.695 B
ICE NYSE Intercontinental Exchange Inc Fair Value Undervalued Market Cap 87.28 B
BN NYSE Brookfield Corp Fair Value Fair Market Cap 83.795 B
MCO NYSE Moodys Corporation Fair Value Fair Market Cap 81.151 B
BAM NYSE Brookfield Asset Management Inc Fair Value Fair Market Cap 73.598 B